DOI : 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 03 · Volume 123 · March 2015 DOI: 10.1055/s-005-28790


58th Symposium of the German Society of Endocrinology (DGE)
Lübeck, 18.–21. März 2015

Presidents: Prof. Dr. Sebastian M. Schmid, Prof. Dr. Henrik Oster; Secretaries: Dr. S. Fliedner and F. Machleidt
Abstracts (HTML) List of Authors
P09_01
Sbiera, S; Fassnacht, M; Leich, E; Liebisch, G; Schirbel, A; Wiemer, L; Matysik, S; Vanselow, JT; Gardill, F; Gehl, A; Kendl, S; König, M; Bala, M; Ronchi, C; Deutschbein, T; Schlosser, A; Schmitz, G; Rosenwald, A; Allolio, B; Kroiß, M: Mitotane inhibits sterol-o-acyltransferase leading to lipid-mediated endoplasmic reticulum stress and apoptosis of adrenocortical carcinoma cells
P09_02
Fuß, CT; Heinze, B; Hirsch, K; Lang, K; Ronchi, C; Wild, V; Allolio, B; Hahner, S: High expression of C-X-C chemokine receptor type 4 in the zona glomerulosa and in aldosterone producing adenoma
P09_03
Gebhard, C; Rhayem, Y; Dietz, AS; Riester, A; Reincke, M; Beuschlein, F: CAV1.3, HSD3B2 and CYP11B2 immunoexpressions in aldosterone-producing adenoma are not correlated with post-adrenalectomy outcome in primary aldosteronism
P09_04
Meyer, G; Badenhoop, K; Linder, R: Risk for adrenal crises is remarkably increased in patients with the autoimmune polyglandular syndrome: German health insurance data 2010 – 2013
P09_05
Koch, M; Badenhoop, K; Meyer, G: Long-term assessment of AddiQoL in patients with Addison's disease may help to identify patients at high risk for crises
P09_06
Kanczkowski, W; Neuwirth, A; Grossklaus, S; Zacharowski, K; Chavakis, T; Bornstein, SR: The role of hematopoietic TLR-signaling in sepsis-associated adrenal inflammation and the HPA axis activation
P09_07
Müller, P; Theisgen, S; Schirbel, A; Sbiera, S; Haralampiev, I; Fassnacht, M; Huster, D; Kroiß, M: Mitotane directly interacts with lipid membranes and alters membrane structure and dynamics
P09_08
Burger-Stritt, S; Spinnler, C; Lang, K; Milovanovic, D; Beuschlein, F; Willenberg, H; Quinkler, M; Allolio, B; Hahner, S: General morbidity and working capacity in patients with chronic adrenal insufficiency – A prospective study
P09_09
Sánchez-Guijo, A; Oji, V; Hartmann, MF; Schuppe, HC; Traupe, H; Wudy, S: 27-hydroxycholesterol-3-sulfate: A new biomarker for human steroid sulfatase deficiency
P09_10
Pflüger, L; Johar, H; Thwing Emeny, R; Heier, M; Reincke, M; Ladwig, KH; Bidlingmaier, M: Increased late night salivary cortisol in the elderly: Cross-sectional and longitudinal observations in a population based study
P09_11
Bergmann, T; Porst, A; Buchfelder, M; Schoefl, C: Cardiovascular and metabolic risk factors in endogenous Cushing's syndrome – Before and after successful treatment
P09_12
Dietz, A; Fischer, E; Riester, A; Treitl, M; Beuschlein, F; Bidlingmaier, M; Reincke, M: Clinical and biochemical outcome after unilateral adrenalectomy in primary aldosteronism
P09_13
Schulz, J; Kötz, K; Ventz, M; Diederich, S; Quinkler, M: Reduction in daily hydrocortisone dose in adrenal insufficiency improves significantly bone mineral density – Results from a 2-years prospective trial
P09_14
Quinkler, M; Ekman, B; Marelli, C; Zelissen, P; Murray, R: Current conventional glucocorticoid therapy in Europe – Insights from the European Adrenal Insufficiency Registry (EuAIR)
P09_15
Walter, C; Maison, N; Beuschlein, F; Meyer, G; Badenhoop, K; Stalla, GK; Quinkler, M; Schoefl, C: Poor adherence of patients with chronic adrenal insufficiency to medical advice in daily life
P09_16
Auer, M; Tao, X; Roepke, Y; Stalla, GK; Stieg, M; van Caenegem, E; Prehn, C; Wang-Sattler, R; Adamski, J; T' sjoen, G: Pilot study on the effects of cross-sex hormone treatment in transsexual persons on metabolism by means of metabolomics profiling
P09_17
Heinze, B; Schirbel, A; Herrmann, K; Buck, A; Blümel, C; Hänscheid, H; Michelmann, D; Nannen, L; Fassnacht, M; Allolio, B; Hahner, S: [123/131I](R)-1-[1-(4-iodophenyl)ethyl]-1H-imidazole-5-carboxylic acid azetidinylamide (IMAZA) – A novel radiotracer for diagnosis and treatment of adrenocortical tumours – From bench to bedside
P09_18
Fischer, E; Pallauf, A; Bekeran, M; Dietz, A; Lang, K; Hanslik, G; Bidlingmaier, M; Beuschlein, F; Quinkler, M; Reincke, M: Primary aldosteronism and the occurrence of hyperparathyroidism in the German Conn's registry
P09_19
Other, K; Heinze, B; Ronchi, C; Hirsch, K; Wild, V; Fassnacht, M; Hahner, S: Chemokine receptor 7 is highly expressed in the adrenal cortex and in benign and malignant adrenocortical tumours but does not show prognostic relevance in adrenal cancer
P09_20
Kulle, AE; Riepe, F; Hedderich, J; Holterhus, PM: Basal and ACTH-stimulated plasma concentrations of 11 steroid hormones using LC-MSMS: Implications for detecting heterozygote CYP21A2 mutation carriers
P09_21
Berr, C; Reincke, M: Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology
P09_22
Peitzsch, M; Bursztyn, M; Pamporaki, C; Därr, R; Fliedner, S; Timmers, H; Lenders, J; Prejbisz, A; Eisenhofer, G: Biochemical diagnosis of pheochromocytoma by measurements of overnight excretion levels of catecholamines and metabolites as a simplified alternative to 24-hour collections
P09_23
Stindl, J; Tauber, P; Sterner, C; Tegtmeier, I; Warth, R; Bandulik, S: Pathophysiology of Na+/K+-atpases in aldosterone secretion
P09_24
Tauber, P; Christ, C; Tegtmeier, I; Fischer, A; Rhayem, Y; Warth, R; Bandulik, S: Cellular pathology of the mutated plasma membrane Ca2+ atpase ATP2B3 found in adrenal adenomas
P09_25
Lichtenauer, U; Schmid, PL; Oßwald, A; Renner-Müller, I; Reincke, M; Warth, R; Wolf, E; Beuschlein, F: Establishment of an in vivo model for KCNJ5 dependent hyperaldosteronism
P09_26
Droste, M; Pahl, S; Norkeweit, J: Structured education and treatment program for patients with adrenal insufficiency – A pilot project
P09_27
Oßwald, A; Plomer, E; Berr, C; Ritzel, K; Schopohl, J; Beuschlein, F; Reincke, M: Cardiovascular morbidity in patients with suspected Cushing's syndrome. A prospective evaluation of the German Cushing's registry